1-20 of 20
Authors: Damian Stichel
Journal Article
BIOM-51. MOLECULAR SUBTYPES, CLINICAL CHARACTERISTICS, AND THERAPEUTIC IMPLICATIONS FOR CNS TUMORS WITHBCOR/BCORL1 FUSION/INTERNAL TANDEM DUPLICATION
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii31, https://doi.org/10.1093/neuonc/noae165.0123
Published: 11 November 2024
Journal Article
LGG-17. EPIGENETICALLY DEFINED ANGIOCENTRIC GLIOMAS MAY LACK ANGIOCENTRIC GROWTH AND INSTEAD SHOW A VARIETY OF GROWTH PATTERNS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i59–i60, https://doi.org/10.1093/neuonc/noad073.227
Published: 12 June 2023
Journal Article
PATH-46. COMPUTATIONAL HISTOPATHOLOGY INFORMED RAPID TARGETED NANOPORE SEQUENCING ENABLES AFFORDABLE NEXT DAY REPORTING OF COMPREHENSIVE MOLECULAR MARKERS FOR CNS TUMOUR DIAGNOSTICS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii161, https://doi.org/10.1093/neuonc/noac209.619
Published: 14 November 2022
Journal Article
ETMR-06. Molecular and clinical characteristics of CNS tumors withBCOR(L1) fusion/internal tandem duplication
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i50, https://doi.org/10.1093/neuonc/noac079.184
Published: 03 June 2022
Journal Article
OTHR-41. Amplification of the PLAG family genes – PLAGL1 and PLAGL2 – is a key feature of a novel embryonal CNS tumor type
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i156, https://doi.org/10.1093/neuonc/noac079.579
Published: 03 June 2022
Journal Article
RARE-15. Astroblastoma, MN1 altered comprises two molecularly and clinically distinct subgroups defined by the fusion partners BEND2 and CXXC5
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i12–i13, https://doi.org/10.1093/neuonc/noac079.040
Published: 03 June 2022
Journal Article
PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i158, https://doi.org/10.1093/neuonc/noac079.587
Published: 03 June 2022
Journal Article
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma
Neuro-Oncology, Volume 24, Issue 12, December 2022, Pages 2121–2132, https://doi.org/10.1093/neuonc/noac111
Published: 03 May 2022
Journal Article
PATH-48. RAPID-CNS2: RAPID COMPREHENSIVE ADAPTIVE NANOPORE-SEQUENCING OF CNS TUMORS, A PROOF OF CONCEPT STUDY
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi126, https://doi.org/10.1093/neuonc/noab196.500
Published: 12 November 2021
Journal Article
PATH-39. INTEGRATED MOLECULAR-MORPHOLOGICAL MENINGIOMA CLASSIFICATION: A MULTICENTER RETROSPECTIVE ANALYSIS, RETRO- AND PROSPECTIVELY VALIDATED
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi123–vi124, https://doi.org/10.1093/neuonc/noab196.491
Published: 12 November 2021
Journal Article
PATH-23. OLIGOSARCOMA, IDH-MUTANT IS A DISTINCT AGGRESSIVE TYPE
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi119–vi120, https://doi.org/10.1093/neuonc/noab196.475
Published: 12 November 2021
Journal Article
EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i10, https://doi.org/10.1093/neuonc/noab090.039
Published: 01 June 2021
Journal Article
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator
Neuro-Oncology, Volume 23, Issue 9, September 2021, Pages 1576–1585, https://doi.org/10.1093/neuonc/noab031
Published: 16 February 2021
Journal Article
LGG-33. ISOMORPHIC DIFFUSE GLIOMA HAS RECURRENT GENE FUSIONS OF MYBL1 OR MYB AND CAN BE DISTINGUISHED FROM OTHER MYB/MYBL1 ALTERED GLIOMAS BASED ON A DISTINCT MORPHOLOGY AND DNA METHYLATION PROFILE
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii372–iii373, https://doi.org/10.1093/neuonc/noaa222.415
Published: 04 December 2020
Journal Article
PATH-26. RNA SEQUENCING OF FORMALIN-FIXED PARAFFIN-EMBEDDED SPECIMENS IN DIAGNOSTIC ROUTINE IDENTIFIES CLINICALLY RELEVANT GENE FUSIONS
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii429–iii430, https://doi.org/10.1093/neuonc/noaa222.661
Published: 04 December 2020
Journal Article
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Neuro-Oncology, Volume 23, Issue 1, January 2021, Pages 34–43, https://doi.org/10.1093/neuonc/noaa251
Published: 01 November 2020
Journal Article
GENE-06. DISTINCT MOLECULAR SUBGROUPS OF TUMORS OF THE PINEAL REGION CORRELATE WITH CLINICAL PARAMETERS AND GENETIC ALTERATIONS
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Pages ii81–ii82, https://doi.org/10.1093/neuonc/noz036.077
Published: 23 April 2019
Journal Article
MNGI-13. A DNA METHYLATION-BASED CLASSIFIER FOR ASSESSMENT OF RISK OF RECURRENCE IN MENINGIOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi151, https://doi.org/10.1093/neuonc/noy148.629
Published: 05 November 2018
Journal Article
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas
Neuro-Oncology, Volume 21, Issue 2, February 2019, Pages 214–221, https://doi.org/10.1093/neuonc/noy155
Published: 25 September 2018
Journal Article
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
Neuro-Oncology, Volume 20, Issue 3, March 2018, Pages 367–379, https://doi.org/10.1093/neuonc/nox160
Published: 24 August 2017
